Diminished androgen levels are linked to irritable bowel syndrome and cause bowel dysfunction in mice
Functional gastrointestinal disorders (FGIDs) have prominent sex differences in incidence, symptoms, and treatment response that are not well understood. Androgens are steroid hormones present at much higher levels in males than females and could be involved in these differences. In adults with irri...
| Published in: | The Journal of Clinical Investigation |
|---|---|
| Main Authors: | Daniella Rastelli, Ariel Robinson, Valentina N. Lagomarsino, Lynley T. Matthews, Rafla Hassan, Kristina Perez, William Dan, Peter D. Yim, Madison Mixer, Aleksandra Prochera, Amy Shepherd, Liang Sun, Kathryn Hall, Sarah Ballou, Anthony Lembo, Judy Nee, Meenakshi Rao |
| Format: | Article |
| Language: | English |
| Published: |
American Society for Clinical Investigation
2022-01-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1172/JCI150789 |
Similar Items
Role of Nutrition in Gastroesophageal Reflux, Irritable Bowel Syndrome, Celiac Disease, and Inflammatory Bowel Disease
by: Amisha Ahuja, et al.
Published: (2023-01-01)
by: Amisha Ahuja, et al.
Published: (2023-01-01)
Targeting hyaluronan synthesis enhances the therapeutic effectiveness of biologics in inflammatory bowel disease
by: Peng Xiao, et al.
Published: (2025-01-01)
by: Peng Xiao, et al.
Published: (2025-01-01)
Gut-microbiota-based ensemble model predicts prognosis of pediatric inflammatory bowel disease
by: Sung Min Ha, et al.
Published: (2024-12-01)
by: Sung Min Ha, et al.
Published: (2024-12-01)
Tackling Irritable Bowel Syndrome with Modern Resources – A Narrative Review
by: Mihai-Radu PAHOMEANU, et al.
Published: (2025-03-01)
by: Mihai-Radu PAHOMEANU, et al.
Published: (2025-03-01)
Gut-directed hypnosis and hypnotherapy for irritable bowel syndrome: a mini-review
by: Winfried Häuser, et al.
Published: (2024-06-01)
by: Winfried Häuser, et al.
Published: (2024-06-01)
Gene coexpression networks reveal a broad role for lncRNAs in inflammatory bowel disease
by: John L. Johnson, et al.
Published: (2024-02-01)
by: John L. Johnson, et al.
Published: (2024-02-01)
The IRE1α/XBP1 pathway sustains cytokine responses of group 3 innate lymphoid cells in inflammatory bowel disease
by: Siyan Cao, et al.
Published: (2024-07-01)
by: Siyan Cao, et al.
Published: (2024-07-01)
Longitudinal single-cell analysis of glucagon-like peptide-2 treatment in patients with short bowel syndrome
by: Yumi Kudo, et al.
Published: (2025-09-01)
by: Yumi Kudo, et al.
Published: (2025-09-01)
Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study): protocol for a partially randomized patient preference trial
by: Yu Minhao
Published: (2022-02-01)
by: Yu Minhao
Published: (2022-02-01)
Immunological Linkages Between Inflammatory Bowel Diseases and Type 2 Diabetes
by: Davide Frumento, et al.
Published: (2025-09-01)
by: Davide Frumento, et al.
Published: (2025-09-01)
Liver Disease Associated with Inflammatory Bowel Disease
by: Juferdy Kurniawan, et al.
Published: (2024-05-01)
by: Juferdy Kurniawan, et al.
Published: (2024-05-01)
Parent and Family Functioning in Pediatric Inflammatory Bowel Disease
by: Grace Cushman, et al.
Published: (2020-10-01)
by: Grace Cushman, et al.
Published: (2020-10-01)
Role of computed tomography enteroclysis in the evaluation of small bowel diseases
by: Safeeq Ahmed Meeran S, et al.
Published: (2024-10-01)
by: Safeeq Ahmed Meeran S, et al.
Published: (2024-10-01)
Serum D-Lactate Concentrations in Dogs with Inflammatory Bowel Disease
by: Giulia Maggi, et al.
Published: (2024-06-01)
by: Giulia Maggi, et al.
Published: (2024-06-01)
Genomic Effects Associated With Response to Placebo Treatment in a Randomized Trial of Irritable Bowel Syndrome
by: Rui-Sheng Wang, et al.
Published: (2022-01-01)
by: Rui-Sheng Wang, et al.
Published: (2022-01-01)
On the Pathogenesis of the Irritable Bowel Syndrome: The Irritable Bowel or the Irritable Patient?
by: Stephen M Collins
Published: (1990-01-01)
by: Stephen M Collins
Published: (1990-01-01)
Monocytes Count, NLR, MLR and PLR in Canine Inflammatory Bowel Disease
by: Maria Chiara Marchesi, et al.
Published: (2024-03-01)
by: Maria Chiara Marchesi, et al.
Published: (2024-03-01)
Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome
by: Jan Vollert, et al.
Published: (2022-03-01)
by: Jan Vollert, et al.
Published: (2022-03-01)
Targeting gut microbiota dysbiosis in inflammatory bowel disease: a systematic review of current evidence
by: Asmaa Farah, et al.
Published: (2025-02-01)
by: Asmaa Farah, et al.
Published: (2025-02-01)
Hemolytic anemia after switching from infliximab originator to biosimilar CT‐P13 in a patient with inflammatory bowel disease: A case report
by: Anne S. Strik, et al.
Published: (2019-11-01)
by: Anne S. Strik, et al.
Published: (2019-11-01)
Comprehensive Review of Ustekinumab Utilization in Inflammatory Bowel Diseases: Insights from the ClinicalTrials.gov Registry
by: Alorfi NM, et al.
Published: (2023-09-01)
by: Alorfi NM, et al.
Published: (2023-09-01)
Dual Biologic Therapy in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Retrospective Study
by: Magdalena Wlazło, et al.
Published: (2022-12-01)
by: Magdalena Wlazło, et al.
Published: (2022-12-01)
Evaluating the use of a customized digital navigation program to optimize bowel preparation in pediatric colonsocopy
by: Lauren Dankner, et al.
Published: (2023-10-01)
by: Lauren Dankner, et al.
Published: (2023-10-01)
Ensuring the Future Pool of Gastroenterologists in the United Kingdom Is Imperative
by: Hareesha Rishab Bharadwaj, et al.
Published: (2024-12-01)
by: Hareesha Rishab Bharadwaj, et al.
Published: (2024-12-01)
Profiling the inflammatory bowel diseases using genetics, serum biomarkers, and smoking information
by: Ruize Liu, et al.
Published: (2023-10-01)
by: Ruize Liu, et al.
Published: (2023-10-01)
Irritable Bowel Syndrome/Inflammatory Bowel Disease Overlap: Less Common Than We Think
by: Lauren K. Burdine, et al.
Published: (2024-01-01)
by: Lauren K. Burdine, et al.
Published: (2024-01-01)
Enteric glia in homeostasis and disease: From fundamental biology to human pathology
by: Harry J. Rosenberg, et al.
Published: (2021-08-01)
by: Harry J. Rosenberg, et al.
Published: (2021-08-01)
Irritable Bowel Syndrome
by: Per G. Farup, et al.
Published: (2012-01-01)
by: Per G. Farup, et al.
Published: (2012-01-01)
The Irritable Bowel Syndrome
by: N.B. Hershfield
Published: (1988-01-01)
by: N.B. Hershfield
Published: (1988-01-01)
Defining the irritable bowel
by: Kee Huat Chuah, et al.
Published: (2022-04-01)
by: Kee Huat Chuah, et al.
Published: (2022-04-01)
The irritable bowel syndrome
by: Vaerenbergh Wim, et al.
Published: (1998-01-01)
by: Vaerenbergh Wim, et al.
Published: (1998-01-01)
Non-Emergent Early Surgical Management for Adhesive Small Bowel Obstruction
by: Sawsan J. Horani, et al.
Published: (2021-07-01)
by: Sawsan J. Horani, et al.
Published: (2021-07-01)
Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine
by: Mauro Bafutto, et al.
Published: (2011-03-01)
by: Mauro Bafutto, et al.
Published: (2011-03-01)
Effect of prebiotic oligosaccharides on bowel habit and the gut microbiota in children with functional constipation (Inside study): study protocol for a randomised, placebo-controlled, multi-centre trial
by: Carrie A. M. Wegh, et al.
Published: (2024-04-01)
by: Carrie A. M. Wegh, et al.
Published: (2024-04-01)
Refractory Irritable Bowel Syndrome and Functional Abdominal Pain Syndrome: Should Small Bowel Endoscopy Be Performed?
by: Sung Kyun Yim, et al.
Published: (2018-11-01)
by: Sung Kyun Yim, et al.
Published: (2018-11-01)
Volatomics in inflammatory bowel disease and irritable bowel syndrome
by: Kathleen Van Malderen, et al.
Published: (2020-04-01)
by: Kathleen Van Malderen, et al.
Published: (2020-04-01)
Leveraging Institutional Support to Build an Integrated Multidisciplinary Care Model in Pediatric Inflammatory Bowel Disease
by: Jennifer Verrill Schurman, et al.
Published: (2021-04-01)
by: Jennifer Verrill Schurman, et al.
Published: (2021-04-01)
Economic impact of industry-sponsored clinical trials in inflammatory bowel diseases: Results from the national institute of gastroenterology “Saverio de Bellis”
by: Maurizio Gaetano Polignano, et al.
Published: (2022-11-01)
by: Maurizio Gaetano Polignano, et al.
Published: (2022-11-01)
AI-assisted discovery of an ethnicity-influenced driver of cell transformation in esophageal and gastroesophageal junction adenocarcinomas
by: Pradipta Ghosh, et al.
Published: (2022-09-01)
by: Pradipta Ghosh, et al.
Published: (2022-09-01)
How to Revitalize the Abdominal Ultrasonography Education Program
by: Beom Kyung Kim, et al.
Published: (2019-02-01)
by: Beom Kyung Kim, et al.
Published: (2019-02-01)
Similar Items
-
Role of Nutrition in Gastroesophageal Reflux, Irritable Bowel Syndrome, Celiac Disease, and Inflammatory Bowel Disease
by: Amisha Ahuja, et al.
Published: (2023-01-01) -
Targeting hyaluronan synthesis enhances the therapeutic effectiveness of biologics in inflammatory bowel disease
by: Peng Xiao, et al.
Published: (2025-01-01) -
Gut-microbiota-based ensemble model predicts prognosis of pediatric inflammatory bowel disease
by: Sung Min Ha, et al.
Published: (2024-12-01) -
Tackling Irritable Bowel Syndrome with Modern Resources – A Narrative Review
by: Mihai-Radu PAHOMEANU, et al.
Published: (2025-03-01) -
Gut-directed hypnosis and hypnotherapy for irritable bowel syndrome: a mini-review
by: Winfried Häuser, et al.
Published: (2024-06-01)
